Answers are grounded in this paper and cite their sources.
Congress has modified regulations of the Food and Drug Administration to promote research assessing the efficacy and safety of drugs in children. The authors examine how this legislation has affected pediatric drug development and research over the past 20 years and discuss options for additional reforms to accelerate progress in this area.
No takes yet. Share an insight, caveat, or question.
Bourgeois et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: